Vivo Capital VIII, LLC is 10% Owner at Crinetics Pharmaceuticals, Inc. (CRNX). They have made 7 open-market trades across 4 companies since 2017, most recently 2023-11-21.
CIK 0001618789
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $996K since 2017, against 6 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 83% | 83% | 67% |
| Avg Move | -11.3% | -24.6% | -10.5% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BOLT | SELL | 2023-11-21 | 2023-11-22 | $0.90 | $3K | -0.3% | +7.0% | +23.3% |
| CRNX | SELL | 2020-03-09 | 2020-03-11 | $19.50 | $10K | -7.1% | -3.3% | +11.9% |
| CRNX | SELL | 2020-02-07 | 2020-02-11 | $21.58 | $418K | +1.3% | -40.9% | -13.1% |
| BPMX | SELL | 2019-06-25 | 2019-06-27 | $1.02 | $669K | -9.8% | -30.1% | -43.1% |
| BPMX | SELL | 2018-03-07 | 2018-03-09 | $0.36 | $720K | -15.8% | -37.4% | -29.4% |
| BPMX | SELL | 2017-11-09 | 2017-11-13 | $0.20 | $119K | -35.9% | -42.7% | -12.8% |
| NBRV | BUY | 2017-09-18 | 2017-09-18 | $9.46 | $996K | -16.7% | -31.4% | -40.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.